Aquestive Therapeutics, Inc. AQST Business Segments
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| License and royalty revenue a | $500K-90.7% | $5.4M+533% | $852K-17.9% | $1.04M+23.7% | $839K+6.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Aquestive Therapeutics, Inc. break its business down?
- Aquestive Therapeutics, Inc. (AQST) reports revenue by product across 4 parts — Co-development and research fees, License and royalty revenue a, Manufacture and supply revenue and Proprietary product revenue, net. Each is extracted from the segment footnotes and tracked over time.
- Where does Aquestive Therapeutics, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Aquestive Therapeutics, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
